Urologic Oncology-Seminars and Original Investigations

Papers
(The H4-Index of Urologic Oncology-Seminars and Original Investigations is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Editorial Board51
Prognostic significance of complete blood count parameters in castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitors46
Interpreting nephrometry scores with three-dimensional virtual modelling for better planning of robotic partial nephrectomy and predicting complications43
Predictive value of renal tumor contour irregularity score in pathological T3a upstaging of clinical T1 renal cell carcinoma: A multi-institutional study43
An update on the pathology of collecting duct & papillary renal cell carcinoma with a discussion of SNP-Arrays as an emerging laboratory technique32
Differences in cancer presentation, treatment, and mortality between rural and urban patients diagnosed with kidney cancer in the United States29
Meta-analysis of perioperative immunotherapy in renal cell carcinoma: Available, but the jury is still out29
Characteristics, trends, and management of Penile cancer in the United States: A population-based study27
Introduction to the seminar on “the impact of complications on surgeons”27
Confronting the inevitable: When a urologist feels like a second victim26
Complications and Surgeon Health: Resources for individuals and institutions26
Prognostic value of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC)25
Durability of response of UGN-101: Longitudinal follow up of multicenter study25
The emotional toll of surgical complications in the early career25
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey24
Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposure23
Concordance of surgical treatment selection with the AUA guidelines for localized renal masses23
Adjuvant immunotherapy in high-risk muscle invasive urothelial carcinoma: A systematic review and meta-analysis of randomized clinical trials22
Integrated care among patients with kidney or urinary bladder cancer: An NCI patterns-of-care analysis22
The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis22
Exploring prostate-specific antigen (PSA) Testing rates and screening disparities in the all of us dataset22
Editorial Board22
0.11618494987488